ATTD

@ATTDconf

The 13th International Conference on Advanced Technologies & Treatments for Diabetes ()

Madrid, Spain
attd.kenes.com
Prikaz prijenosa uživo Prijenos UŽIVO
Vrijeme pridruživanja: veljača 2015.
549 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @ATTDconf

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ATTDconf

  1. Prikvačeni tweet
    11. pro 2019.

    Why join us at ? 👉"You'll join people that come because they want to contribute, they want to be part of a group of people that really move things forward, that make a significant change for people with .". ➡️⬅️

    2 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    prije 22 sata

    - The 13th in Madrid on 19-22 Feb will showcase the latest innovations and research in technologies & treatments. Learn more:

    3 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  3. prije 11 sati

    Get your ticket today! Last chance to register and save! Claim your spot amongst more than 3000 professionals from around the globe, working together to move the field forward. 👉 Register NOW:

    Poništi
  4. proslijedio/la je Tweet
    1. velj

    Are you going to in Madrid? You really should come along to ! It’s open to everyone! And it’s FREE! cc:

    6 proslijeđenih tweetova 14 korisnika označava da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    3. velj

    “Given a cure always takes at least five, I think I’d put my money on this!” Looking forward to reports from about the tech magic that looks set to transform in the near future.

    Could it be magic? A potential future for users of type 1 diabetes technology…
    2 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  6. 4. velj

    2 days left to save on registration fees! Are you joining us at in Madrid? Take the opportunity and register today: We are looking forward to meeting you all!

    2 proslijeđena tweeta 3 korisnika označavaju da im se sviđa
    Poništi
  7. 3. velj

    Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Aspart (NovoLog) When Used in in Adults with : A Randomized, Open-Label Clinical Trial Read more:

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
    Poništi
  8. proslijedio/la je Tweet
    1. velj

    Looking forward to some interesting sessions as organised by et al Some interesting topics but maybe could be more...controversial in future This session, however? Should be....interesting to chair and speak at 🙂 Shall I mention...pancakes?

    , , i još njih 5
    6 proslijeđenih tweetova 34 korisnika označavaju da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    1. velj

    I'm looking forward to taking on at the symposium debate "Tubeless: pump form matters". See you there!

    Looking forward to some interesting sessions as organised by et al Some interesting topics but maybe could be more...controversial in future This session, however? Should be....interesting to chair and speak at 🙂 Shall I mention...pancakes?
    4 proslijeđena tweeta 18 korisnika označava da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    30. sij

    Slides done for already. Some kind of personal record methinks! are the themes (unsurprisingly) .

    1 proslijeđeni tweet 10 korisnika označava da im se sviđa
    Poništi
  11. 30. sij

    Tasting no-calorie sweetener may affect response on tolerance test via

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    21. sij

    Calling all ATTD delegates, full details of our workshop: DIY AP Systems: What Should the Guidelines Include? Thur, 20th Feb 12.00-12.50pm LONDON Room Revital Nimri clinical perspective user perspective ethics perspective 25 mins - open discussion

    15 proslijeđenih tweetova 23 korisnika označavaju da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    28. sij

    will showcase the latest , research in Tech & Treatments and advancements for . Be part of the discussion! Madrid 19-22 Feb

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    29. sij

    We won a grant and will participate to the 13th in Madrid. We will share a booth with our For more infos, visit our website:

    2 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  15. 29. sij

    You have 1 week to save on registration fees for ! Meet. Discuss. Innovate. Let's enhance the development of novel technologies and treatments for together. Register Now:

    , , i još njih 4
    6 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    28. sij

    If you wonder how musculoskeletal disorders (MSKDs) can impact the use of technology by people with , have a look at our e-poster during . I will be more than happy to share😀 See you there ! 👍

    1 proslijeđeni tweet 12 korisnika označava da im se sviđa
    Poništi
  17. 27. sij

    Read this article about the Evolution of . Want to learn more? Join us at next month and let's discuss the future of together!

    4 proslijeđena tweeta 8 korisnika označava da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    27. sij

    Elevated levels of glucose-dependent insulinotropic peptide are associated with higher mortality risk in two prospective, community-based studies 🔓

    16 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Poništi
  19. 23. sij

    Diabetes drug costs have soared in South Essex, following the continued climb of the prevalence of the condition. Read more in the article

    1 proslijeđeni tweet
    Poništi
  20. proslijedio/la je Tweet
    22. sij

    Creo que el jueves 20 de febrero la frustración inundará mi ser… ¿Cómo voy a estar en 4 lugares al mismo tiempo?! Será por eso que es mi congreso favorito? ;) El programa completo en

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Poništi
  21. proslijedio/la je Tweet
    22. sij

    بالإمكان الإطلاع على برنامج المؤتمر الدولي للتكنولوجيا المتقدمة وعلاج السكري المقام في مدريد التاسع عشر من فبراير ٢٠٢٠ عبر الرابط التالي:

    4 proslijeđena tweeta 1 korisnik označava da mu se sviđa
    Poništi

@ATTDconf još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·